Heart and Diabetes Center North Rhine-Westphalia
13
4
5
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.7%
1 terminated/withdrawn out of 13 trials
83.3%
-3.2% vs industry average
8%
1 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
TRICuspid Intervention in Heart Failure Trial
Role: collaborator
A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
Role: collaborator
Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes
Role: collaborator
Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach
Role: collaborator
The Ablate-by-LAW Study
Role: collaborator
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended
Role: collaborator
Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3
Role: collaborator
Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)
Role: collaborator
Specific PoC Testing of Coagulation in Patients Treated With DOAC 1
Role: collaborator
German Registry for Transcatheter Tricuspid Valve Interventions
Role: collaborator
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
Role: collaborator
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1
Role: collaborator
Patients Perception of Mechanical Heart Valve Sounds: Psychoacoustics and Quality of Life
Role: collaborator
All 13 trials loaded